[Skip to Navigation]
Comment & Response
June 2018

Adjunctive Intranasal Esketamine in Treatment-Resistant Depression—Reply

Author Affiliations
  • 1Department of Neuroscience, Janssen Research & Development, LLC, Titusville, New Jersey
  • 2Department of Neuroscience, Janssen Research & Development, LLC, San Diego, California
JAMA Psychiatry. 2018;75(6):654-655. doi:10.1001/jamapsychiatry.2018.0430
Add or change institution
×